Literature DB >> 24877857

Changes in health related quality of life in women and men undergoing radiation treatment for head and neck cancer and the impact of smoking status in the radiation treatment period.

Helen Egestad1, Nina Emaus2.   

Abstract

PURPOSE: The aim of this study was to evaluate health-related quality of life (HRQOL) in women and men undergoing radiation treatment for head and neck cancer through the intervention period and examine if age, body mass index (BMI) and smoking status at baseline may modify changes in HRQOL.
METHODS: HRQOL was examined by the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and the EORTC QLQ-H&N35, in the beginning and end of the treatment period in 65 patients at the University Hospital in Northern Norway. Changes in HRQOL were calculated and compared by paired sample T-tests. Linear multiple regression analyses were used to examine if baseline characteristics had any influence towards HRQOL changes.
RESULTS: Most aspects of HRQOL declined substantially and significantly (p < 0.001) with a magnitude of more than one standard deviation during the radiation treatment period irrespective of sex and age. Smoking status at baseline had some, albeit minor, influence on changes in HRQOL. Patients who continued smoking during therapy had significantly higher decline in several aspects of HRQOL, compared to patients who stopped smoking.
CONCLUSIONS: HRQOL declined with substantial magnitude in patients undergoing radiation treatment for head and neck cancer, but smoking cessation may modify the declining quality of life.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EORTC QLQ-C30; EORTC QLQ-H&N35; Head and neck cancer; Health-related quality of life; Prospective cohort study; Radiation therapy

Mesh:

Year:  2014        PMID: 24877857     DOI: 10.1016/j.ejon.2014.04.003

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  7 in total

1.  Development of a Targeted Smoking Relapse-Prevention Intervention for Cancer Patients.

Authors:  Lauren R Meltzer; Cathy D Meade; Diana B Diaz; Monica S Carrington; Thomas H Brandon; Paul B Jacobsen; Judith C McCaffrey; Eric B Haura; Vani N Simmons
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

2.  Does smoking abstinence predict cancer patients' quality of life over time?

Authors:  Úrsula Martínez; Karen O Brandon; Steven K Sutton; Thomas H Brandon; Vani N Simmons
Journal:  Psychooncology       Date:  2019-07-02       Impact factor: 3.894

3.  Smoking relapse-prevention intervention for cancer patients: Study design and baseline data from the surviving SmokeFree randomized controlled trial.

Authors:  Diana B Díaz; Thomas H Brandon; Steven K Sutton; Lauren R Meltzer; Hannah J Hoehn; Cathy D Meade; Paul B Jacobsen; Judith C McCaffrey; Eric B Haura; Hui-Yi Lin; Vani N Simmons
Journal:  Contemp Clin Trials       Date:  2016-07-25       Impact factor: 2.226

4.  Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.

Authors:  Eleni M Rettig; Gypsyamber D'Souza; Carol B Thompson; Wayne M Koch; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2016-05-16       Impact factor: 6.860

5.  Differences in quality of life in obese and normal weight head and neck cancer patients undergoing radiation therapy.

Authors:  Helen Egestad; Carsten Nieder
Journal:  Support Care Cancer       Date:  2014-10-04       Impact factor: 3.603

6.  Oral complications at 6 months after radiation therapy for head and neck cancer.

Authors:  R V Lalla; N Treister; T Sollecito; B Schmidt; L L Patton; K Mohammadi; J S Hodges; M T Brennan
Journal:  Oral Dis       Date:  2017-08-03       Impact factor: 3.511

Review 7.  Impact of Tobacco Smoking on Outcomes of Radiotherapy: A Narrative Review.

Authors:  Adrian Perdyan; Jacek Jassem
Journal:  Curr Oncol       Date:  2022-03-24       Impact factor: 3.109

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.